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Unconventional secretion and subsequent uptake of molecular cargo via extracellular
vesicles (EVs) is an important mechanism by which cells can exert paracrine effects. While
this phenomenon has been widely characterized in the context of their ability to promote
inflammation, less is known about the ability of EVs to transfer immunosuppressive
cargo. Maintenance of normal physiology in the lung requires suppression of potentially
damaging inflammatory responses to the myriad of insults to which it is continually
exposed. Recently, our laboratory has reported the ability of alveolar macrophages
(AMs) to secrete suppressors of cytokine signaling (SOCS) proteins within microvesicles
(MVs) and exosomes (Exos). Uptake of these EVs by alveolar epithelial cells (AECs)
resulted in inhibition of pro-inflammatory STAT activation in response to cytokines.
Moreover, AM packaging of SOCS within EVs could be rapidly tuned in response to
exogenous or AEC-derived substances. In this article we will highlight gaps in knowledge
regardingmicroenvironmental modulation of cargo packaging and utilization as well as EV
secretion and uptake. Advances in these areas are critical for improving understanding
of intercellular communication in the immune system and for therapeutic application
of artificial vesicles aimed at treatment of diseases characterized by dysregulated
inflammation.
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INTRODUCTION
Intercellular communication is vital for multicellular organisms to respond and adapt to changes
in the environment. It is a cornerstone of the immune response and is classically accomplished
via either direct cell-cell contact or secretion of soluble mediators. Extracellular vesicles (EVs)
have emerged recently as additional vectors of communication and represent an area of intense
investigation. EVs are small membrane-delimited packets which, by transferring diverse forms of
biologically active cargo (lipids, RNA, DNA, soluble and surface proteins) from donor to recipient
cells, participate in both homeostasis and disease. EVs comprise a spectrum of structures that
vary in size, membranes of origin, mechanisms of release, and surface and internal cargo. The
best characterized subsets of these are microvesicles (MVs) and exosomes (Exos). MVs originate
by direct plasma membrane budding and are ∼100–1000 nm in diameter, while Exos originate
from endosomal membranes within multivesicular bodies and are ∼30–150 nm in diameter.
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A number of steps in vesicle trafficking ultimately dictate
transduction of information (Figure 1); these include cargo
sorting into vesicles and vesicle formation and release from
source cells, as well as vesicle uptake and cargo utilization within
target cells. Fundamental mechanisms governing these processes
under normal conditions are beginning to be elucidated, yet how
these steps are modulated by external or microenvironmental
cues remains poorly understood, and is a focus of this review.
Comprising an enormous direct interface with the outside
environment, the alveolar surface of the lung is uniquely
exposed to diverse challenges including microbes, pollutants,
and antigens. Preserving the delicate alveolar epithelial barrier
to ensure maintenance of gas exchange in the face of this
continual and dynamic onslaught requires a tightly-regulated
host immune response. The key cellular players responsible for
immune and inflammatory responses at this interface are the
alveolar epithelial cells (AECs)—which comprise the surface—
and alveolar macrophages (AMs)—the resident immune cell
of the distal lung. We have recently identified a novel means
for maintaining immune homeostasis at this site in which
inflammatory signaling within AECs is restrained by AM-
derived EVs. We were interested to find that various aspects
of vesicular cargo trafficking can additionally be modulated by
distinct environmental cues. In this brief review, we place this
concept of microenvironmental influence on EV communication
in a broader context of immune function. We then discuss the
implications of these findings in directing future studies on
translational aspects of vesicles in diagnosis and treatment of
disease.
EXTRACELLULAR VESICLES IN IMMUNE
FUNCTION
Although EVs have been identified in virtually all organ systems,
they have been most extensively studied in vascular and cancer
biology (reviewed in Desrochers et al., 2016; Osteikoetxea
et al., 2016). However, a growing body of recent literature has
implicated EVs in the pathogenesis and—to a lesser extent—the
resolution of inflammation (Norling and Dalli, 2013; Fernández-
Messina et al., 2015), and have shown convincing evidence of
functionally relevant EV-mediated delivery to target cells of cargo
including lipids (Tang et al., 2010), mRNA (Valadi et al., 2007),
and miRNA (Pegtel et al., 2010). Very little is known about the
role of EVs in lung physiology. Recently, our lab has discovered
a novel mechanism by which AMs can modulate host response
through immunosuppressive EVs.
TRANSCELLULAR MODULATION OF
IMMUNE FUNCTION IN THE ALVEOLAR
MICROENVIRONMENT
Phosphorylation and activation of the STAT family of
transcription factors by JAK kinases is integral to transduction of
inflammatory signals in response to cytokines. STAT-dependent
transcription of inflammatory genes such as chemokines by
AECs plays an important role in leukocyte recruitment to
the alveolar space. The endogenous brake on this pathway is
the family of SOCS proteins, which can directly inhibit STAT
activation. Although SOCS proteins had never been identified
previously in the extracellular space, we found that AMs
constitutively secrete two distinct SOCS proteins (SOCS1 and
SOCS3) within EVs (Bourdonnay et al., 2015). Furthermore,
considering the aforementioned importance of restraining
inflammation in the lung, we were surprised to find that AECs
express very little endogenous SOCS3 protein, although this is
consistent with immunohistochemical analysis of normal lung
(Akram et al., 2014). This led us to hypothesize that AM release
of EV-contained SOCS proteins may serve as an “external”
source of SOCS for AECs during inflammatory responses. Both
conditioned medium (CM) from AMs as well as EVs purified
from AM CM possessed the ability to inhibit cytokine-induced
STAT activation and expression of a STAT-dependent gene
product, MCP-1 (or CCL-2) in AECs in vitro and in the lung
in vivo. This inhibitory effect in AECs was eliminated when either
SOCS1 or SOCS3 expression was silenced in the source AMs.
Lung lavage fluid from healthy smoking humans, or from mice
subjected to smoke exposure for several days, showed reduced
SOCS levels within MVs. These results, summarized in Figure 2,
suggest that constitutive elaboration of SOCS proteins by AMs
restrains inflammatory signaling in the alveolar epithelium, but
that this process is impaired during smoking. We speculate that
this “brake malfunction” facilitates inflammatory responses to
smoking.
CARGO SELECTION
In order for EVs to be meaningful regulators of the immune
response, their cargo should be subject to dynamic selection
in response to microenvironmental cues. Although EV cargo is
dictated by the intracellular contents of its source cell, differences
in profiles implying selective cargo packaging into vesicles are
well-recognized. Since proteins which lack N-terminal signal
sequences—such as SOCS proteins—cannot be secreted via
a classical endoplasmic reticulum-Golgi pathway, it is not
surprising that these are preferentially secreted within vesicles
(Nickel and Rabouille, 2009). Additionally, ubiquitination of
specific proteins actively targets them to endosomal sorting
complexes required for transport into vesicles (Hanson and
Cashikar, 2012). However, preferential packaging of cargo
within distinct vesicle populations is less well-appreciated.
Surprisingly, differential ultracentrifugation to separate these two
EV subpopulations revealed that SOCS1 was primarily packaged
within smaller Exos and SOCS3 within larger MVs (Figure 2).
Exclusion of these fractions from AM CM abrogated their
inhibitory effect on STAT activation in response to cytokines
(Bourdonnay et al., 2015). Given the demonstrated effects of
EVs on immunomodulation and the concept that the immune
response is dictated by changes in the environment, especially
applicable to the lung, it becomes essential to understand how
these changes alter vesicular cargo trafficking.
We also found that brief (15–60min) direct exposure of
AMs to the classic inflammatory stimulus LPS inhibited SOCS
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FIGURE 1 | General schematic of EV biogenesis and uptake. EV cargo can be sorted into two distinct EV populations: Exos or MVs. Exos are generated via
inward budding of the multivesicular body (MVB) membrane and subsequently released via fusion of MVBs with the plasma membrane. MVs are generated by direct
outward budding and fission of the plasma membrane. Uptake of EVs can be accomplished by either direct membrane fusion and release of EV contents into the
target cell cytoplasm, or through various forms of endocytosis. Finally, the fate of the intravesicular cargo can be influenced by the form of uptake and the ability of the
contents to avoid lysosomal degradation.
secretion, while the anti-inflammatory mediators IL-10 and
prostaglandin E2 (PGE2) increased SOCS secretion. The rapidity
of these effects argues that transcriptional mechanisms were
not operative. Interestingly, these effects also occurred in the
absence of any change in the numbers of EVs secreted, indicating
that these substances alter the packaging of SOCS proteins
within the EVs (Bourdonnay et al., 2015; Figure 2). Since little
is known of the molecular mechanisms by which cytosolic
proteins such as SOCS 1 and 3 are selectively packaged into EVs,
how environmental factors further shape their sorting remains
unexplained. The capacity for SOCS packaging within EVs to be
rapidly increased by mediators also suggested a possible means
by which AECs could “instruct” AMs to secrete additional SOCS
if needed. Indeed, AMs exposed to CM isolated from AECs
pretreated for 24 h by LPS exhibited enhanced SOCS3 secretion
(Speth et al., 2016). This indirect enhancement of AM SOCS3
secretion in response to LPS-stimulated AEC-derived factors was
in stark contrast to the direct inhibitory effect of acute (1–2 h)
LPS exposure on AMs. As AECs produced high levels of PGE2 in
response to LPS treatment, we employed both pharmacologic and
genetic inhibition of PGE2 synthesis to demonstrate that PGE2
elaboration by AECs served as the “request signal” for enhanced
SOCS3 secretion by AMs (Speth et al., 2016; Figure 2). This form
of EV-mediated crosstalk represents a way in which AMs can
dynamically respond to microenvironmental cues to constrain
endogenous inflammation in AECs during an innate immune
response.
EV SECRETION
There are many reported examples in which the number of
released EVs is regulated by cues external to the source cell.
LPS stimulation of dendritic cells (DCs) increases the number
and changes the composition of MVs released (Obregon et al.,
2006; Nolte-’t Hoen et al., 2013). Exos were released from
DCs following T cell interaction with peptide-loaded MHC
class II on DCs (Buschow et al., 2009). T cells also secrete
Exos upon CD3 T cell receptor cross-linking (Blanchard et al.,
2002). Mast cells release EVs in response to changes in Ca++
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FIGURE 2 | AM and AEC crosstalk in the lung. AMs release Exos and MVs containing SOCS1 and SOCS3, respectively. Positive regulators of SOCS release
include the bioactive lipid PGE2, the cytokine IL-10, and AEC-derived mediators in response to LPS and infection. Negative regulators include acute, direct AM
exposure of LPS, and cigarette smoke. AEC uptake of SOCS-containing EVs might likewise be modulated by constituents of the normal alveolar milieu or by
exogenous factors to which the lung is exposed. Additionally, EV uptake by AECs results in inhibition of cytokine-induced STAT activation.
concentration in association with the process of degranulation
(Raposo et al., 1997). Even though we observed no change
in the numbers of SOCS-containing EVs in response to the
stimuli discussed above, AM adherence to plastic, which is well
known to trigger Ca++ influx and cellular activation, did result
in increased EV secretion. ESCRT complexes, tetraspannins,
membrane lectins, heat shock proteins, membrane curvature,
and surface proteins are all reported to play a role in secretion
of vesicles (Yáñez-Mo et al., 2015) and thus may mediate
some of these changes in vesiculation in response to external
stimuli.
EV UPTAKE
Information transfer via EVs requires that they either be
internalized by, or trigger a plasma membrane-based response
in, the target cells. Various forms of endocytosis represent
the predominant internalization pathway reported for both
MVs and Exos in target cells, with lesser roles reported for
membrane fusion, micropinocytosis, and phagocytosis (reviewed
in Mulcahy et al., 2014). In contrast to mechanisms governing
vesicle formation and secretion, a clear divergence between
uptake mechanisms for MVs and Exos has not been established.
However, uptake of EVs is subject to physiologic regulation.
As an example, vasopressin enhances uptake of EVs in the
renal collecting system (Oosthuyzen et al., 2016). Transformed
tumor cells have heightened uptake efficiency when compared
to their pre-transformed counterparts (Nakase et al., 2015).
The acidic pH of the tumor microenvironment has been
suggested to facilitate membrane fusion of vesicles with recipient
cells (Parolini et al., 2009). Secreted lipases from platelets in
the context of inflammation enhance uptake of MVs into
neutrophils (Duchez et al., 2015), although the mechanism for
this effect remains uncertain. Our lab is currently investigating
the impact of normal and pathologic extracellular constituents
on uptake of MVs within AECs. Thus, like cargo selection
and secretion of vesicles, uptake represents an additional
step in vesicle trafficking that can be modulated by relevant
microenvironmental substances.
FUNCTIONAL UTILIZATION OF EV CARGO
The question of how cargo within internalized EVs ultimately
reaches the compartments within recipient cells in which it
can be functionally active remains enigmatic. This challenge
is vividly illustrated by the case of SOCS proteins transferred
in AM-derived EVs, which must reach the cytosol of recipient
AECs in order to effectively inhibit STAT phosphorylation.
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One might imagine that membrane-membrane fusion would
be the ideal uptake mechanism to enable cargo to circumvent
the lysosomal degradation pathway and be delivered into the
cytosol. But, as noted above, most reports favor endocytosis
over membrane-membrane fusion as the operative mechanism
in uptake. Investigators have endeavored to enhance the
efficiency of membrane fusion by engineering EVs containing
specific surface proteins. However, such modifications have
been reported to both increase (Temchura et al., 2008) and
decrease (Maguire et al., 2012) the delivery of functionally
active cargo in recipient cells. Thus, engineering of vesicles
for optimal delivery of functional cargo—important for
their potential therapeutic applicability—depends on an
understanding of factors facilitating the ultimate utilization of
cargo.
EV SIGNALING WITH INFECTIOUS
CHALLENGES
Infections pose the most common challenge to the immune
system, particularly in the lung. We have also investigated
the effects of lung infection on SOCS packaging within AM-
derived vesicles. In contrast to what we observed in cigarette
smoking, the lungs of mice subjected to both viral and bacterial
infection had increased levels of SOCS3 within MVs, in the
absence of any change in MV number (Speth et al., 2016).
By contrast, no change in SOCS1 levels within Exos was seen.
We speculate that differential regulation of vesicular packaging
of these two SOCS family members may reflect an attempt
to restrain excessive pathologic inflammation (accomplished by
increasing SOCS3) without compromising protective STAT-1-
mediated antimicrobial defense (which would be inhibited by
SOCS1).
That viral particles and host-derived vesicles share similar
pathways of cellular exit and entry has not escaped attention, and
this topic has been extensively reviewed (vanDongen et al., 2016).
Classically, viruses can evade the immune response by mutating
their surface proteins or by inducing immunosuppressive
changes within specific cell types (Hashimoto et al., 2009;
Ramakrishnaiah et al., 2013; Sun et al., 2014). Recent
studies reveal that key viral proteins and/or nucleic acids
are secreted from infected cells within host-derived vesicles with
corresponding host surface proteins (Robinson et al., 2014),
thus facilitating immune evasion while retaining their infectious
capacity. Other reports, however, demonstrate that viral species
ejected within host derived MVs are internalized more efficiently
by dendritic cells (Feng et al., 2015), and this may represent an
adaptation of the infected cell to facilitate immune capture of
viral particles attempting to infect other cells. As consideration
is given to the development of vesicle-based therapeutics,
understanding mechanisms involved in cargo sorting in various
contexts is imperative in order to deduce which scenarios reflect
viral attempts at immune evasion and which are sophisticated
host-derived immune defense mechanisms.
EVS AS BIOMARKERS
As readily measurable indicators of a disease process or its
progression, biomarkers can facilitate the ability of clinicians
to diagnose, prognosticate, and measure responses to therapy.
While tissue biopsy sampling represents the gold standard
in providing relevant histopathologic or molecular diagnostic
information, such approaches are invasive and subject to risk,
can yield false negative results, and provide only a single
snapshot in time. The concept of a “liquid biopsy” is gaining
favor (Karachaliou et al., 2015) as a means to overcome such
limitations, with EVs within relevant body fluids emerging as
leading contenders to provide a lens onto dynamic internal
pathophysiologic processes such as immune disorders. Decreased
(as in smoking) or increased (as in infection) levels of vesicular
SOCS in lung lavage fluid may provide useful information about
lung immune status, but their utility as biomarkers will require
them being readily measured by more accessible means, such as
plasma, exhaled breath condensate, or saliva.
CONCLUSIONS
Herein we have reviewed our recently published data on
transcellular delivery of SOCS proteins from AMs to AECs as a
means of restraining inflammation on the pulmonary alveolar
surface (Bourdonnay et al., 2015; Speth et al., 2016). We have
used our findings regarding modulation of SOCS packaging
within EVs and of EV uptake by relevant microenvironmental
determinants to illustrate how aspects of vesicle trafficking and
cargo delivery can be regulated in a dynamic manner, and to
highlight significant gaps in current knowledge. Our own studies
have focused on the novel role of SOCS proteins, but the effects
of environmental cues on the global content and delivery of
vesicular protein, lipid, and nucleic acid cargo, of course, remains
to be elucidated.
AUTHOR CONTRIBUTIONS
All authors listed, have made substantial, direct and intellectual
contribution to the work, and approved it for publication.
FUNDING
This work is supported by NIH R01 HL-125555 (to MP-G). JMS
was supported by NIH T32 HL-774923.
REFERENCES
Akram, K. M., Lomas, N. J., Forsyth, N. R., and Spiteri, M. A. (2014). Alveolar
epithelial cells in idiopathic pulmonary fibrosis display upregulation of TRAIL,
DR4 and DR5 expression with simultaneous preferential over-expression of
pro-apoptotic marker p53. Int. J. Clin. Exp. Pathol. 7, 552–564.
Blanchard, N., Lankar, D., Faure, F., Regnault, A., Dumont, C., Raposo, G.,
et al. (2002). TCR activation of human T cells induces the production of
Frontiers in Cell and Developmental Biology | www.frontiersin.org 5 August 2016 | Volume 4 | Article 94
Schneider et al. Immunomodulatory Extracellular Vesicles in Lung
exosomes bearing the TCR/CD3/zeta complex. J. Immunol. 168, 3235–3241.
doi: 10.4049/jimmunol.168.7.3235
Bourdonnay, E., Zaslona, Z., Penke, L. R., Speth, J. M., Schneider, D. J.,
Przybranowski, S., et al. (2015). Transcellular delivery of vesicular SOCS
proteins from macrophages to epithelial cells blunts inflammatory signaling.
J. Exp. Med. 212, 729–742. doi: 10.1084/jem.20141675
Buschow, S. I., Nolte-’t Hoen, E. N., van Niel, G., Pols, M. S., ten Broeke, T.,
Lauwen, M., et al. (2009). MHC II in dendritic cells is targeted to lysosomes
or T cell-induced exosomes via distinct multivesicular body pathways. Traffic
10, 1528–1542. doi: 10.1111/j.1600-0854.2009.00963.x
Desrochers, L. M., Antonyak, M. A., and Cerione, R. A. (2016). Extracellular
vesicles: satellites of information transfer in cancer and stem cell biology. Dev.
Cell 37, 301–309. doi: 10.1016/j.devcel.2016.04.019
Duchez, A. C., Boudreau, L. H., Naika, G. S., Bollinger, J., Belleannee, C., Cloutier,
N., et al. (2015). Platelet microparticles are internalized in neutrophils via the
concerted activity of 12-lipoxygenase and secreted phospholipase A2-IIA. Proc.
Natl. Acad. Sci. U.S.A. 112, E3564–E3573. doi: 10.1073/pnas.1507905112
Feng, Z., Li, Y., McKnight, K. L., Hensley, L., Lanford, R. E., Walker, C. M., et al.
(2015). Human pDCs preferentially sense enveloped hepatitis A virions. J. Clin.
Invest. 125, 169–176. doi: 10.1172/JCI77527
Fernández-Messina, L., Gutierrez-Vazquez, C., Rivas-Garcia, E., Sanchez-
Madrid, F., and de la Fuente, H. (2015). Immunomodulatory role of
microRNAs transferred by extracellular vesicles. Biol. Cell 107, 61–77. doi:
10.1111/boc.201400081
Hanson, P. I., and Cashikar, A. (2012). Multivesicular body morphogenesis. Annu.
Rev. Cell Dev. Biol. 28, 337–362. doi: 10.1146/annurev-cellbio-092910-154152
Hashimoto, K., Ishibashi, K., Ishioka, K., Zhao, D., Sato, M., Ohara, S., et al.
(2009). RSV replication is attenuated by counteracting expression of the
suppressor of cytokine signaling (SOCS) molecules. Virology 391, 162–170. doi:
10.1016/j.virol.2009.06.026
Karachaliou, N., Mayo-de-Las-Casas, C., Molina-Vila, M. A., and Rosell, R. (2015).
Real-time liquid biopsies become a reality in cancer treatment. Ann. Transl.
Med. 3, 36. doi: 10.3978/j.issn.2305-5839.2015.01.16
Maguire, C. A., Balaj, L., Sivaraman, S., Crommentuijn, M. H., Ericsson, M.,
Mincheva-Nilsson, L., et al. (2012). Microvesicle-associated AAV vector as
a novel gene delivery system. Mol. Ther. 20, 960–971. doi: 10.1038/mt.
2011.303
Mulcahy, L. A., Pink, R. C., and Carter, D. R. (2014). Routes and mechanisms of
extracellular vesicle uptake. J. Extracell Vesicles 3. doi: 10.3402/jev.v3.24641
Nakase, I., Kobayashi, N. B., Takatani-Nakase, T., and Yoshida, T. (2015). Active
macropinocytosis induction by stimulation of epidermal growth factor receptor
and oncogenic Ras expression potentiates cellular uptake efficacy of exosomes.
Sci. Rep. 5:10300. doi: 10.1038/srep10300
Nickel, W., and Rabouille, C. (2009). Mechanisms of regulated unconventional
protein secretion. Nat. Rev. Mol. Cell Biol. 10, 148–155. doi: 10.1038/
nrm2617
Nolte-’t Hoen, E. N., van der Vlist, E. J., de Boer-Brouwer, M., Arkesteijn,
G. J., Stoorvogel, W., and Wauben, M. H. (2013). Dynamics of dendritic
cell-derived vesicles: high-resolution flow cytometric analysis of extracellular
vesicle quantity and quality. J. Leukoc. Biol. 93, 395–402. doi: 10.1189/jlb.
0911480
Norling, L. V., and Dalli, J. (2013). Microparticles are novel effectors of immunity.
Curr. Opin. Pharmacol. 13, 570–575. doi: 10.1016/j.coph.2013.05.008
Obregon, C., Rothen-Rutishauser, B., Gitahi, S. K., Gehr, P., and Nicod, L. P.
(2006). Exovesicles from human activated dendritic cells fuse with resting
dendritic cells, allowing them to present alloantigens. Am. J. Pathol. 169,
2127–2136. doi: 10.2353/ajpath.2006.060453
Oosthuyzen, W., Scullion, K. M., Ivy, J. R., Morrison, E. E., Hunter, R. W., Starkey
Lewis, P. J., et al. (2016). Vasopressin regulates extracellular vesicle uptake by
kidney collecting duct cells. J. Am. Soc. Nephrol. doi: 10.1681/ASN.2015050568.
[Epub ahead of print].
Osteikoetxea, X., Nemeth, A., Sodar, B. W., Vukman, K. V., and
Buzas, E. I. (2016). Extracellular vesicles in cardiovascular disease:
are they Jedi or Sith? J. Physiol. 594, 2881–2894. doi: 10.1113/JP
271336
Parolini, I., Federici, C., Raggi, C., Lugini, L., Palleschi, S., De Milito, A., et al.
(2009). Microenvironmental pH is a key factor for exosome traffic in tumor
cells. J. Biol. Chem. 284, 34211–34222. doi: 10.1074/jbc.M109.041152
Pegtel, D. M., Cosmopoulos, K., Thorley-Lawson, D. A., van Eijndhoven, M.
A., Hopmans, E. S., Lindenberg, J. L., et al. (2010). Functional delivery of
viral miRNAs via exosomes. Proc. Natl. Acad. Sci. U.S.A. 107, 6328–6333. doi:
10.1073/pnas.0914843107
Ramakrishnaiah, V., Thumann, C., Fofana, I., Habersetzer, F., Pan, Q., de Ruiter, P.
E., et al. (2013). Exosome-mediated transmission of hepatitis C virus between
human hepatoma Huh7.5 cells. Proc. Natl. Acad. Sci. U.S.A. 110, 13109–13113.
doi: 10.1073/pnas.1221899110
Raposo, G., Tenza, D., Mecheri, S., Peronet, R., Bonnerot, C., and Desaymard, C.
(1997). Accumulation of major histocompatibility complex class II molecules
in mast cell secretory granules and their release upon degranulation.Mol. Biol.
Cell 8, 2631–2645.
Robinson, S. M., Tsueng, G., Sin, J., Mangale, V., Rahawi, S., McIntyre,
L. L., et al. (2014). Coxsackievirus B exits the host cell in shed
microvesicles displaying autophagosomal markers. PLoS Pathog. 10:e1004045.
doi: 10.1371/journal.ppat.1004045
Speth, J. M., Bourdonnay, E., Penke, L. R., Mancuso, P., Moore, B. B., Weinberg,
J. B., et al. (2016). Alveolar epithelial cell-derived prostaglandin E2 serves
as a request signal for macrophage secretion of suppressor of cytokine
signaling 3 during innate inflammation. J. Immunol. 196, 5112–5120. doi:
10.4049/jimmunol.1502153
Sun, K., Salmon, S., Yajjala, V. K., Bauer, C., andMetzger, D.W. (2014). Expression
of suppressor of cytokine signaling 1 (SOCS1) impairs viral clearance and
exacerbates lung injury during influenza infection. PLoS Pathog. 10:e1004560.
doi: 10.1371/journal.ppat.1004560
Tang, K., Liu, J., Yang, Z., Zhang, B., Zhang, H., Huang, C., et al. (2010).
Microparticles mediate enzyme transfer from platelets to mast cells: a new
pathway for lipoxin A4 biosynthesis. Biochem. Biophys. Res. Commun. 400,
432–436. doi: 10.1016/j.bbrc.2010.08.095
Temchura, V. V., Tenbusch, M., Nchinda, G., Nabi, G., Tippler, B., Zelenyuk,
M., et al. (2008). Enhancement of immunostimulatory properties of exosomal
vaccines by incorporation of fusion-competent G protein of vesicular stomatitis
virus. Vaccine 26, 3662–3672. doi: 10.1016/j.vaccine.2008.04.069
Valadi, H., Ekstrom, K., Bossios, A., Sjostrand, M., Lee, J. J., and Lotvall, J. O.
(2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel
mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654–659. doi:
10.1038/ncb1596
van Dongen, H. M., Masoumi, N., Witwer, K. W., and Pegtel, D. M. (2016).
Extracellular vesicles exploit viral entry routes for cargo delivery. Microbiol.
Mol. Biol. Rev. 80, 369–386. doi: 10.1128/MMBR.00063-15
Yáñez-Mo, M., Siljander, P. R., Andreu, Z., Zavec, A. B., Borras, F. E., Buzas,
E. I., et al. (2015). Biological properties of extracellular vesicles and their
physiological functions. J. Extracell Vesicles 4:27066. doi: 10.3402/jev.v4.27066
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
The handling Editor declared a shared affiliation, though no other collaboration,
with the authors and states that the process nevertheless met the standards of a
fair and objective review.
Copyright © 2016 Schneider, Speth and Peters-Golden. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Cell and Developmental Biology | www.frontiersin.org 6 August 2016 | Volume 4 | Article 94
